An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

02 Jan 20264 min read0 viewsOBSERVATIONAL Trial

GIST

RECRUITING · OBSERVATIONAL · Hepatocellular Carcinoma (HCC) · Enrollment 80 · Sponsor: University Hospital, Ghent

Clinical Editorial

Summary

ClinicalTrials.gov published a clinical update in Oncology on 02 Jan 2026. The item focuses on An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer. Open the detail page to review the full original feed content.